Net Loss Per Share - Additional information (Details) - Cara Therapeutics Inc. - Subsequent Event - shares	May 13, 2025	Apr. 15, 2025
Net Loss Per Share
Number of shares issued upon conversion of debt	1,265,757	1,265,757
Number of converted shares upon closing of merger	6,539,404

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration